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Abstract 
Purpose: To investigate the antifungal activities.of the individual as well as the combined hydroalcohol 
leaf and root extracts of endemic Hypericum havvae A. Guner (Hyperiaceae). 
Methods: Each dry powdered plant material (20 g) was soaked in 150 ml of aqueous ethanol (50: 50 
%v/v) until complete saturation of the plant material. After the extracts were filtered and evaporated, the 
antifungal activity of the extracts was tested against medical yeast, Candida (C. albicans ATCC 10231, 
C. tropicalis ATCC 13808, C. guilliermondii ATCC 6260) and Cryptococcus (C. neoformans ATCC 
90112 and C. laurentii 34142) species by visual broth microdilution method. Minimum inhibitory 
concentration (MIC) of the extract was derived from the results. Ketoconazole was used as the 
reference standard. 
Results: MIC values ranged from 3.12 to 25.00 mg/ml. The extracts exhibited strong antifungal effect 
against the yeast cultures but the combination of the plant extracts (leaf + root) possessed stronger 
antifungal potency against Candida albicans and Cryptococcus laurentii, with the same MIC value of 
1.56 mg/ml.  
Conclusion: Our findings support the use of Hypericum havvae in traditional medicine for the treatment 
of fungal infections, especially Candidiasis.  
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Hypericum species belonging to Clusiaceae 
(Hyperiaceae) family are widely found in Europe, 
Asia, Northern Africa and America [1]. This 
genus encompasses various species used in 
traditional medicine around the world. Several 
antifungal, antibiotic, antiviral and anticancer 
compounds have been isolated from Hypericum 
species [2-4]. The majority of the active 
compounds are phenolic in nature. These plants 
have a strong tendency to accumulate phenolic 
compounds with the pholoroglucinol substitution 
pattern.  
Hypericum havvae A. Guner is endemic to 
Turkey [5]. Information gathered from native 
healers indicate that the powdered form or water 
extract are used as antidepressant drug. The 
plant is also used for other therapeutic purposes 
by native Turkish people. During our routine field 
excursions, it was observed that this plant is 
used to treat colds and bronchitis, externally for 
boils and abscesses, and for urinary tract 
infections. Therefore, this study was undertaken 
to determine the antifungal effects of the 
hydroethanol extracts obtained from this endemic 
plant against some Candida and Cryptococcus 
species. 
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The plant material was collected from Icel-
Cehennemdere, Turkey, 37°07’36.13’’ N, 
34°31’03.31’’ E, alt. 725 m in September, 2012. 
The plant was collected and identified by Dr. 
Gorkem Dulger. Voucher specimens of the plant 
(no. GD-056-1 for the leaves and no. GD-056-2 
for the root) were deposited in herbarium of the 
Biology Department, Duzce University. 
 
Preparation of extracts 
 
The plant parts were washed and air-dried. Each 
dry powdered plant material (20 g) was soaked in 
150 mL of aqueous ethanol (50: 50 %v/v) until 
complete saturation of the plant material. The 
extract was filtered using Whatman no. 1, the 
filtrate then evaporated under reduced pressure 
and dried using a rotary evaporator at 55 °C. The 
extract (in the form of sticky black substances) 
amounting to 2 mg was dissolved in 0.4 mL of 
dimethyl sulfoxide (DMSO, 5 mg/mL). The 
combination of plant extracts (1:1 ratio) was used 
in this test [6]. Candida species (C. albicans 
ATCC 10231, C. tropicalis ATCC 13808, C. 
guilliermondii ATCC 6260) and Cryptococcus 
species (C. neoformans ATCC 90112 and C. 
laurentii 34142) the test fungi, were obtained 
from Research Laboratory in Duzce University, 
Department of Biology, Turkey and pure cultures 
were maintained on Sabouraud Dextrose Agar 
(SDA) plates and Sabouraud Dextrose Broth 
(SDB) in tubes. 
 
Minimum inhibitory concentration (MIC) 
determination 
 
MIC’s were performed by the visual broth 
macrodilution method [7]. Fungal suspensions 
were diluted into RPMI 1640 medium (with l-
glutamine, without bicarbonate) (Sigma Aldrich 
Chemie GmbH, Steinheim, Germany) buffered to 
pH 7.0 with 0.165 M morpholinepropanesulfonic 
acid (MOPS; Sigma-Aldrich Chemie GmbH, 
Steinheim, Germany) to a concentration of 
approximately 0.5x105 CFU/mL, verified by 
colony count in SDA. 
 
A two-fold serial dilution of 0.2 mL each of extract 
was added to 1.8 mL of the RPMI-1640 Medium. 
The concentrations were in the range 0.39 – 
200.0 mg/mL. Controls with medium without 
antifungal samples were included in the test. For 
comparison, ketoconazole was used as 
standard. The tubes were incubated at 35 °C for 
24 - 48 h. MIC was defined as the lowest 
concentration which did not yield visual growth. 




The MICs of the extracts are presented in Table 
1. The MIC results for the ethanol extracts of 
leaf, root and their combination ranged from 3.12 
- 25, 6.25 - 25 and 1.56 - 12.5 mg/mL, 
respectively; the results show that the 
susceptibility of the extracts varied from one 
fungal strain to another. The combined plant 
extracts (leaf plus root) exhibited stronger 
antifungal activity than the others. Candida 
albicans and Cryptococcus laurentii were more 
susceptible than other fungi, followed by Candida 
tropicalis, Candida guilliermondii and 
Cryptococcus neoformans, with the same MIC of 
3.12 mg/mL. . The combined extracts with the 
same MIC of 12.5 mg/mL have shown weak 
activity against Candida glabrata and Candida 
parapsilosis. Notably, the combined extracts 
displayed stronger antifungal activity than the 
standard antifungal antibiotic, ketoconazole,  
against Candida albicans, Candida tropicalis and 




Fungi used in this study were chosen primarily 
on the basis of their importance as opportunistic 
pathogens of humans. According to the findings 
of National Nosocomial Infection Surveillance 
System (NNIS), 61 % of reported nosocomial 
fungal infections were due to Candida albicans, 
followed by other Candida spp. and 
Cryptococcus spp. [8]. In a previous study, 
ethanol (95 %) was observed as the best solvent 
for extracting antimicrobial substances [9]. The 
results in this study, obtained with 50 % aqueous 
ethanol extract, are similar to those reported in 
that study. It is important to bear in mind that the 
concentration of extract used in the test may 
correlate with the activity of its chemical 
components.  
 
In another study, n-hexane, ethyl acetate, 
ethanol and aqueous extracts of Hypericum 
havvae were tested for their antimicrobial activity 
against Escherichia coli, Enterobacter 
aerogenes, Alcaligenes faecalis, Salmonella 
typhimurium, Citrobacter freundii, 
Staphylococcus aureus, Bacillus cereus, Bacillus 
subtilis, Bacillus brevis, Pseudomonas 
aeruginosa, Proteus vulgaris, Micrococcus 
luteus, Micrococcus flavus, Candida albicans, 
Rhodotorula rubra and Kluyveromyces fragilis 
[10]. While extracts of the plant have shown  
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Leaf and root  
(1:1 ratio) (mg/mL) 
Ketoconazole 
(µg/mL) 
Candida albicans  3.12 6.25 1.56 0.25 
Candida tropicalis 6.25 12.5 3.12 4 
Candida guilliermondii 6.25 12.5 3.12 5 
Candida krusei 12.5 25 6.25 4 
Candida glabrata 25 25 12.5 2 
Candida parapsilosis 25 25 12.5 2 
Cryptococcus neoformans 6.25 12.5 3.12 0.25 
Cryptococcus laurentii 3.12 6.25 1.56 4 
 
strong antimicrobial activity against the test 
bacteria, they exhibited weak activity against the 
test yeast cultures.  
 
Aqueous and ethanolic extracts obtained from H. 
havvae have been investigated previously for its 
ability to inhibit 35 hospital isolates of methicillin-
resistant Staphylococcus aureus (MRSA). Both 
aqueous and ethanol extracts of the plant were 
effective against MRSA. MIC and MBC values of 
the ethanol extract were 0.8 - 3.2 mg/mL and 1.6 
- 6.3 mg/mL, respectively [11]. Based on our 
findings, the extracts of H. havvae showed strong 
antifungal activity against both Candida and 
Cryptococcus species. The difference between 
our results and those of other investigations may 
be due to several factors, such as intra-specific 
variability in the production of secondary 
metabolites. In addition, there may be differences 
in the extraction protocols used to recover the 
active metabolites as well as differences in the 
assay methods. 
 
Hypericum species contain many phenolic 
compounds (hypericin, hyperforin and their 
derivates, hyperoside, quercetin, chlorogenic 
acid, flavonols and flavones), suggesting that 
they could have important antioxidant properties 
[12]. Hypericin has shown antibacterial and anti-
inflammatory activity and hyperforin is the main 
compound involved in antidepressant activity 
[13]. 
The results indicate that H. havvae exerted 
significant activity against both Candida and 
Cryptococcus species, especially Candida 
albicans and Cryptococcus laurentii.  This activity 
may be indicative of the presence of metabolic 
toxins or the above-mentioned plant compounds. 
Therefore, this plant extract should be analyzed 
further, as it might provide new compounds that 
are effective against pathogens. According to the 
latest report from the National Nosocomial 
Infection Surveillance System (NNIS), 61 % of 
reported nosocomial fungal infections are due to 
Candida albicans, followed by other Candida 




This study provides data on the antifungal 
properties of the hydroethanol extracts of H. 
havvae against some clinically relevant fungi. 
These extracts may be further developed for 
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